Talia N Crawford1, Andrea Y Arikawa2, Mindy S Kurzer2, Kathryn H Schmitz3, William R Phipps4. 1. Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota. 2. Department of Food Science and Nutrition, University of Minnesota, St. Paul, Minnesota. 3. Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania. 4. Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota. Electronic address: wphippsmd@rrc.com.
Abstract
OBJECTIVE: To assess the relationship between SHBG and 18 other hormonal and metabolic parameters in well characterized, normally cycling premenopausal women. DESIGN: Cross-sectional study. SETTING: University general clinical research center. SUBJECT(S): A total of 319 young healthy women with ovulatory menstrual cycles. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Midfollicular serum SHBG concentrations. RESULT(S): In our final linear regression model, SHBG was negatively associated with bioavailable T and positively associated with adiponectin, associations that were independent from other parameters. SHBG was also positively associated with estrone sulfate, but only when taking into account confounding variables. Unexpectedly, there was no straightforward relationship between SHBG and insulin resistance according to homeostasis-model assessment. CONCLUSION(S): Our results highlight the link between androgen action, as reflected by bioavailable T, and circulating SHBG concentrations in all premenopausal women and speak to the importance of the relationship between SHBG and adiponectin, which is at least in part independent from androgen action. CLINICAL TRIAL REGISTRATION NUMBER: NCT00393172.
RCT Entities:
OBJECTIVE: To assess the relationship between SHBG and 18 other hormonal and metabolic parameters in well characterized, normally cycling premenopausal women. DESIGN: Cross-sectional study. SETTING: University general clinical research center. SUBJECT(S): A total of 319 young healthy women with ovulatory menstrual cycles. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Midfollicular serum SHBG concentrations. RESULT(S): In our final linear regression model, SHBG was negatively associated with bioavailable T and positively associated with adiponectin, associations that were independent from other parameters. SHBG was also positively associated with estrone sulfate, but only when taking into account confounding variables. Unexpectedly, there was no straightforward relationship between SHBG and insulin resistance according to homeostasis-model assessment. CONCLUSION(S): Our results highlight the link between androgen action, as reflected by bioavailable T, and circulating SHBG concentrations in all premenopausal women and speak to the importance of the relationship between SHBG and adiponectin, which is at least in part independent from androgen action. CLINICAL TRIAL REGISTRATION NUMBER: NCT00393172.
Authors: Alma J Smith; William R Phipps; William Thomas; Kathryn H Schmitz; Mindy S Kurzer Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-05 Impact factor: 4.254
Authors: Rafael Simó; Cristina Saez-Lopez; Albert Lecube; Cristina Hernandez; Jose Manuel Fort; David M Selva Journal: Endocrinology Date: 2014-05-14 Impact factor: 4.736
Authors: Andrea Y Arikawa; William Thomas; Myron Gross; Alma Smith; William R Phipps; Mindy S Kurzer; Kathryn H Schmitz Journal: Contemp Clin Trials Date: 2012-11-22 Impact factor: 2.226
Authors: Stephen J Winters; Jyothi Gogineni; Marjan Karegar; Charles Scoggins; Chris A Wunderlich; Richard Baumgartner; Dushan T Ghooray Journal: J Clin Endocrinol Metab Date: 2014-12 Impact factor: 5.958
Authors: E H Yeung; C Zhang; P S Albert; S L Mumford; A Ye; N J Perkins; J Wactawski-Wende; E F Schisterman Journal: Int J Obes (Lond) Date: 2012-02-07 Impact factor: 5.095